Arkadios Wealth Advisors Catalent, Inc. Transaction History

Arkadios Wealth Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$87.2 - $114.05 $222,360 - $290,827	-2,550 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$94.19 - $124.49 $240,184 - $317,449	2,550 New	2,550 $283,000
Q4 2021 Feb 03, 2022	SELL	$119.57 - $139.07 $7,652 - $8,900	-64 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$109.17 - $142.35 $61,135 - $79,716	-560 Reduced 89.74%	64 $8,000
Q2 2021 Jul 28, 2021	SELL	$100.34 - $115.69 $200 - $231	-2 Reduced 0.32%	624 $67,000
Q1 2021 Apr 26, 2021	SELL	$101.51 - $125.27 $7,105 - $8,768	-70 Reduced 10.06%	626 $65,000
Q4 2020 Feb 09, 2021	BUY	$85.88 - $105.36 $59,772 - $73,330	696 New	696 $72,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.